J.P. Morgan Initiates Coverage on NuVasive (NUVA) with an Overweight
More News related to NUVA
- NuVasive to Present at 20th Annual Piper Jaffray Health Care Conference
- Needham & Co's Top MedTech Picks: MDT, SYK, ISRG, NUVA
- NuVasive (NUVA) Tops Q3 Views; Raises FY08 Guidance
- Nuvasive Reports Third Quarter 2008 Financial Results
- Brean Murray Initiates Coverage on NuVasive (NUVA) with a Buy
More News related to New Coverage
- Raymond James Starts Millicom (MICC) at Strong Buy
- Stifel Nicolaus Starts City National (CYN) at Hold
- Stifel Nicolaus Starts eHealth (Nasdaq: HLTH) with a Buy
- Wasserman & Associates initiates coverage on American Physicians Service Group (AMPH) with a Buy
- Jesup & Lamont Initiates Coverage on AutoZone (AZO) with a Hold.
J.P. Morgan initiates coverage on NuVasive (Nasdaq: NUVA) with an Overweight.
NuVasive, Inc. (NuVasive) is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.
Related Categories
New CoverageStocks Mentioned
+0.86Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
